(Q44453900)

English

Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial

scientific article published in June 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

extrapyramidal symptoms

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Dora Wynchank

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Human Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

271-275

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Mirtazapine enhances the effect of haloperidol on apomorphine-induced climbing behaviour in mice and attenuates haloperidol-induced catalepsy in rats

1 reference

https://api.crossref.org/works/10.1002%2FHUP.476

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.476

7 January 2021

based on heuristic

inferred from DOI database lookup

5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.476

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences

1 reference

https://api.crossref.org/works/10.1002%2FHUP.476

7 January 2021

based on heuristic

inferred from DOI database lookup

Managing antipsychotic-induced acute and chronic akathisia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.476

7 January 2021

based on heuristic

inferred from DOI database lookup

The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies

1 reference

https://api.crossref.org/works/10.1002%2FHUP.476

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of serotonergic and anticholinergic drugs in haloperidol-induced dystonia in Cebus monkeys.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.476

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug induced psychosis

1 reference

https://api.crossref.org/works/10.1002%2FHUP.476

7 January 2021

based on heuristic

inferred from DOI database lookup

Mirtazapine for neuroleptic-induced akathisia.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.476

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.476

7 January 2021

based on heuristic

inferred from DOI database lookup

Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol

1 reference

https://api.crossref.org/works/10.1002%2FHUP.476

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HUP.476

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44453900&oldid=2024689428"